>北美数字治疗 (DTx) 市场，按产品和服务类型（硬件产品、解决方案/软件、服务）、应用（治疗/护理相关应用、预防应用）、购买模式（团购组织、个人）、销售渠道（B2B、B2C）、国家（美国、加拿大、墨西哥）行业趋势和预测到 2028 年
市场分析和洞察：北美数字治疗 (DTx) 市场
数字治疗 (DTx) 市场预计将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析，在 2021 年至 2028 年的预测期内，该市场的复合年增长率为 23.4%，预计到 2028 年将达到 106.3936 亿美元。糖尿病、高血压等慢性病患病率的不断增加以及政府机构认识的不断提高将促进数字治疗 (DTx) 市场的增长。
数字疗法 (DTx) 使用基于证据的远程评估软件直接向患者提供治疗干预，以治疗、管理和预防各种行为、精神和身体疾病。它们可以单独使用，也可以与药物、设备或其他疗法结合使用，以优化患者护理和健康结果。在治疗过程中，越来越多地远程访问经过临床测试的、安全有效的疗法是数字疗法 (DTx) 的特性之一。
公司为扩大产品线和获取利润而进行的技术进步是数字治疗 (DTx) 市场增长的驱动力之一。与数字治疗 (DTx) 应用程序相关的隐私问题可能会成为数字治疗 (DTx) 市场增长的制约因素。公司之间的合作将有助于市场增长，并为数字治疗 (DTx) 市场带来机遇。为了为客户提供更好的治疗和适当的护理，必须保持数字治疗 (DTx) 的质量，因此，这需要正确完成，因此，这将对数字治疗 (DTx) 市场构成挑战，因为很多时候需求得不到满足。
数字治疗 (DTx) 市场报告提供了市场份额、新发展和产品线分析、国内和本地市场参与者的影响的详细信息，分析了新兴收入领域、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和数字治疗 (DTx) 市场情景，请联系 Data Bridge Market Research 获取分析师简报，我们的团队将帮助您创建收入影响解决方案以实现您的预期目标。
数字治疗 (DTx) 市场范围和市场规模
The digital therapeutic (DTx) market is categorized into four segments which are based on product and service type, application, purchase mode and sales channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of product and service type, the digital therapeutic (DTx) market is segmented into hardware products, solutions/software and service. In 2021, solutions/software segment is expected to dominate the market since there are number of smart phone users being increased.
- On the basis of application, the digital therapeutic (DTx) market is segmented into treatment/ care-related applications and preventive applications. In 2021, treatment/care-related applications segment is expected to dominate since it provides a good treatment and improve the life style of the people.
- On the basis of purchase mode, the digital therapeutic (DTx) market is segmented into group purchase organization and individual. In 2021, individual segment is expected to dominate the market since many people individually are accepting the digital healthcare platform and preferring them in the pandemic situation.
- On the basis of sales channel, the digital therapeutic (DTx) market is segmented into B2B and B2C. In 2021, B2C segment is expected to dominate the market since the services are mostly preferred directly to the customers.
North America Digital Therapeutic (DTx) Market Country Level Analysis
North America digital therapeutic (DTx) market is analysed and market size information is provided by the country, product and service type, application, purchase mode and sales channel as referenced above.
The countries covered in the North America digital therapeutic (DTx) market report are the U.S., Canada and Mexico.
North America region holds the majority of the share in the digital therapeutic (DTx) market and is expected to witness the CAGR during the forecast period due to increasing number of cases in diabetes. The U.S. has the highest household spending in the world and offers trade agreements with several countries making it the largest market for consumer products including digital therapeutic (DTx) products
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
制造商的战略举措为数字治疗 (DTx) 市场参与者创造了新的机遇
数字治疗 (DTx) 市场还为您提供每个国家数字治疗 (DTx) 产品销售增长、数字治疗 (DTx) 进步的影响以及监管环境的变化及其对数字治疗 (DTx) 市场的支持的详细市场分析。数据涵盖 2011 年至 2019 年的历史时期。
竞争格局和数字治疗 (DTx) 市场份额分析
数字治疗 (DTx) 市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用主导地位、技术生命线曲线。以上提供的数据点仅与公司对数字治疗 (DTx) 市场的关注有关。
北美数字治疗 (DTx) 市场报告涵盖的主要参与者包括 Fitbit, Inc.、Livongo、ResMed、Omada Health, Inc.、Noom, Inc.、Happify, Inc.、Welldoc, Inc.、SAMSUNG、ATENTIV、MANGO HEALTH、CogniFit、Kaia Health、Mindstrong Health、Smartpatient gmbh、Ayogo Health Inc.、Ginger、Better Therapeutics, Inc.、2Morrow Inc.、CANARY HEALTH、Click Therapeutics, Inc.、Cognoa、Pear Therapeutics, Inc.、Voluntis、Akili Interactive Labs, Inc. 以及其他国内参与者。DBMR 分析师了解竞争优势并为每个竞争对手分别提供竞争分析。
全球各地的公司也推出了许多产品并达成了多项协议，这也加速了数字治疗 (DTx) 市场的发展。
例如，
- 2019年8月，ATENTIV与儿童专科医院中心达成协议。双方的合作包括共同开发统一的行为和基本治疗操作系统，该系统利用最佳临床实践，供初级保健临床医生使用ATENTIV mynd。此次合作将提高公司的品牌价值和产品的市场价值。
市场参与者的合作、产品发布、业务扩展、奖励和认可、合资企业和其他策略正在增强公司在数字治疗 (DTx) 市场中的市场，这也为组织改善其数字治疗 (DTx) 产品提供了好处。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT AND SERVICE TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 NORTH AMERICA DIGITAL THERAPEUTICS (DTX) MARKET: REGULATIONS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 RISE IN PREVALENCE OF CHRONIC DISEASES
5.1.2 INCREASE IN AWARENESS BY GOVERNMENT AGENCIES
5.1.3 TECHNOLOGICAL ADVANCEMENT IN HEALTHCARE
5.1.4 INCREASED NUMBER OF PEOPLE USING SMARTPHONES
5.1.5 IMPROVED QUALITY OF LIFE
5.2 RESTRAINTS
5.2.1 PATIENT INFORMATION PRIVACY POLICIES
5.2.2 DIGITAL PAYMENT ASSOCIATED WITH DIGITAL THERAPEUTICS
5.2.3 UNDER DEVELOPING COUNTIRES LACKING SMARTPHONES AND INTERNET FACILITIES
5.3 OPPORTUNITIES
5.3.1 RISING DEMAND OF DIGITAL THERAPEUTICS
5.3.2 COLLABORATION BETWEEN COMPANIES TO PROVIDE BETTER PRODUCTS/SERVICES
5.3.3 PARTNERSHIP BETWEEN COMPANIES
5.3.4 EXPANSION AND LAUNCH OF PRODUCTS
5.3.5 EVENTS AND EXHIBITION
5.3.6 PHYSICIAN ADOPTION
5.4 CHALLENGES
5.4.1 CLINICAL VALIDATION
5.4.2 REGULATORY APPROVAL
5.4.3 PAYER REIMBURSEMENT
6 IMPACT OF COVID-19 ON NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET
6.1 IMPACT ON DEMAND
6.2 IMPACT ON SUPPLY
6.3 KEY INITIATIVES TAKEN BY PLAYERS DURING COVID-19
6.4 CONCLUSION
7 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE
7.1 OVERVIEW
7.2 SOLUTION/SOFTWARE
7.3 HARDWARE PRODUCTS
7.4 SERVICE
8 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 TREATMENT/CARE-RELATED APPLIACTIONS
8.2.1 DIABETES
8.2.2 CENTRAL NERVOUS SYSTEM DISORDERS
8.2.3 SMOKING CESSATION
8.2.4 CHRONIC RESPIRATORY DISEASES
8.2.5 MUSCULOSKELETAL DISORDER
8.2.6 CARDIOVASCULAR DISEASES
8.2.7 MEDICATION ADHERENCE
8.2.8 GASTROINTESTINAL DISORDERS
8.2.9 REHABILITATION AND PATIENT CARE
8.2.10 SUBSTANCE USE DISORDER AND ADDICTION MANAGEMENT
8.2.11 OTHER TREATMENT/ CARE RELATED APPLICATIONS
8.3 PREVENTIVE APPLICATIONS
8.3.1 PREDIABETES
8.3.2 OBESITY
8.3.3 NUTRITION
8.3.4 LIFESTYLE MANAGEMENT
8.3.5 OTHER PREVENTIVE APPLICATIONS
9 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE
9.1 OVERVIEW
9.2 GROUP PURCHASE ORGANIZATION
9.2.1 SOLUTIONS/ SOFTWARE
9.2.2 HARDWARE PRODUCT
9.2.3 SERVICE
9.3 INDIVIDUAL
9.3.1 SOLUTIONS/ SOFTWARE
9.3.2 HARDWARE PRODUCT
9.3.3 SERVICE
10 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL
10.1 OVERVIEW
10.2 B2B
10.2.1 PAYERS
10.2.2 EMPLOYERS
10.2.3 PHARMA COMPANIES
10.2.4 PROVIDERS
10.2.5 OTHER BUYERS
10.3 B2C
10.3.1 CAREGIVERS
10.3.2 PATIENTS
11 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY GEOGRAPHY
11.1 NORTH AMERICA
11.1.1 U.S.
11.1.2 CANADA
11.1.3 MEXICO
12 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
13 SWOT
14 COMPANY PROFILE
14.1 FITBIT,INC.
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 COMPANY SHARE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENTS
14.2 LIVONGO
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 COMPANY SHARE ANALYSIS
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPMENTS
14.3 RESMED
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COMPANY SHARE ANALYSIS
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENTS
14.4 OMADA HEALTH, INC.
14.4.1 COMPANY SNAPSHOT
14.4.2 COMPANY SHARE ANALYSIS
14.4.3 PRODUCT PORTFOLIO
14.4.4 RECENT DEVELOPMENTS
14.5 GINGER
14.5.1 COMPANY SNAPSHOT
14.5.2 PRODUCT PORTFOLIO
14.5.3 RECENT DEVELOPMENT
14.6 SAMSUNG
14.6.1 COMPANY SNAPSHOT
14.6.2 REVENUE ANALYSIS
14.6.3 PRODUCT PORTFOLIO
14.6.4 RECENT DEVELOPMENT
14.7 MINDSTRONG HEALTH
14.7.1 COMPANY SNAPSHOT
14.7.2 SERVICE PORTFOLIO
14.7.3 RECENT DEVELOPMENTS
14.8 2MORROW INC.
14.8.1 COMPANY SNAPSHOT
14.8.2 PRODUCT PORTFOLIO
14.8.3 RECENT DEVELOPMENTS
14.9 AKILI INTERACTIVE LABS, INC.
14.9.1 COMPANY SNAPSHOT
14.9.2 PRODUCT PORTFOLIO
14.9.3 RECENT DEVELOPMENTS
14.1 ATENTIV
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENTS
14.11 AYOGO HEALTH INC.
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT DEVELOPMENTS
14.12 BETTER THERAPEUTICS, INC
14.12.1 COMPANY SNAPSHOT
14.12.2 PRODUCT PORTFOLIO
14.12.3 RECENT DEVELOPMENTS
14.13 CANARY HEALTH
14.13.1 COMPANY SNAPSHOT
14.13.2 SOLUTION PORTFOLIO
14.13.3 RECENT DEVELOPMENT
14.14 CLICK THERAPEUTICS, INC.
14.14.1 COMPANY SNAPSHOT
14.14.2 PRODUCT PORTFOLIO
14.14.3 RECENT DEVELOPMENTS
14.15 COGNIFIT
14.15.1 COMPANY SNAPSHOT
14.15.2 PRODUCT PORTFOLIO
14.15.3 RECENT DEVELOPMENTS
14.16 COGNOA
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT DEVELOPMENTS
14.17 GAIA AG
14.17.1 COMPANY SNAPSHOT
14.17.2 PRODUCT PORTFOLIO
14.17.3 RECENT DEVELOPMENTS
14.18 HAPPIFY, INC.
14.18.1 COMPANY SNAPSHOT
14.18.2 PRODUCT PORTFOLIO
14.18.3 RECENT DEVELOPMENTS
14.19 KAIA HEALTH
14.19.1 COMPANY SNAPSHOT
14.19.2 PRODUCT PORTFOLIO
14.19.3 RECENT DEVELOPMENTS
14.2 MANGO HEALTH
14.20.1 COMPANY SNAPSHOT
14.20.2 PRODUCT PORTFOLIO
14.20.3 RECENT DEVELOPMENTS
14.21 NATURAL CYCLES USA CORP
14.21.1 COMPANY SNAPSHOT
14.21.2 PRODUCT PORTFOLIO
14.21.3 RECENT DEVELOPMENT
14.22 NOOM, INC.
14.22.1 COMPANY SNAPSHOT
14.22.2 PRODUCT PORTFOLIO
14.22.3 RECENT DEVELOPMENT
14.23 PEAR THERAPEUTICS, INC.
14.23.1 COMPANY SNAPSHOT
14.23.2 PRODUCT PORTFOLIO
14.23.3 RECENT DEVELOPMENTS
14.24 SMARTPATIENT GMBH
14.24.1 COMPANY SNAPSHOT
14.24.2 PRODUCT PORTFOLIO
14.24.3 RECENT DEVELOPMENT
14.25 VOLUNTIS
14.25.1 COMPANY SNAPSHOT
14.25.2 REVENUE ANALYSIS
14.25.3 PRODUCT PORTFOLIO
14.25.4 RECENT DEVELOPMENTS
14.26 WELLDOC, INC.
14.26.1 COMPANY SNAPSHOT
14.26.2 PRODUCT PORTFOLIO
14.26.3 RECENT DEVELOPMENTS
14.27 WELLTHY THERAPEUTICS PVT LTD
14.27.1 COMPANY SNAPSHOT
14.27.2 PRODUCT PORTFOLIO
14.27.3 RECENT DEVELOPMENTS
15 QUESTIONNAIRE
16 RELATED REPORTS
表格列表
LIST OF TABLES
TABLE 1 REGULATORY FRAMEWORK
TABLE 2 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2020-2028 (USD MILLION)
TABLE 3 NORTH AMERICA SOLUTIONS/SOFTWARE IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION))
TABLE 4 NORTH AMERICA HARDWARE PRODUCTS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 5 NORTH AMERICA SERVICE IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 6 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2020-2028 (USD MILLION)
TABLE 7 NORTH AMERICA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 NORTH AMERICA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 9 NORTH AMERICA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 NORTH AMERICA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 11 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2020-2028 (USD MILLION)
TABLE 12 NORTH AMERICA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 NORTH AMERICA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 14 NORTH AMERICA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 NORTH AMERICA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 16 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2020-2028 (USD MILLION)
TABLE 17 NORTH AMERICA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 NORTH AMERICA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 19 NORTH AMERICA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 NORTH AMERICA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 21 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 22 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 23 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 24 NORTH AMERICA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 25 NORTH AMERICA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 26 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 27 NORTH AMERICA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 28 NORTH AMERICA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 29 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 30 NORTH AMERICA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 31 NORTH AMERICA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 32 U.S. DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 33 U.S. DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 34 U.S. TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 35 U.S. PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 36 U.S. DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 37 U.S. GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 38 U.S. INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 39 U.S. DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 40 U.S. B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 41 U.S. B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 42 CANADA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 43 CANADA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 44 CANADA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 45 CANADA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 46 CANADA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 47 CANADA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 48 CANADA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 49 CANADA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 50 CANADA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 51 CANADA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 52 MEXICO DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 53 MEXICO DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 54 MEXICO TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 55 MEXICO PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 56 MEXICO DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 57 MEXICO GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 58 MEXICO INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 59 MEXICO DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 60 MEXICO B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 61 MEXICO B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
图片列表
LIST OF FIGURES
FIGURE 1 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET : DATA TRIANGULATION
FIGURE 3 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: MULTIVARIATE MODELLING
FIGURE 7 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 10 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: SEGMENTATION
FIGURE 12 INCREASING DEMAND OF DIGITAL THERAPEUTICS WORLDWIDE DUE TO PREVALENCE OF CHRONIC DISEASES IS EXPECTED TO DRIVE THE MARKET GROWTH IN THE FORECAST PERIOD OF 2021 TO 2028.
FIGURE 13 SOLUTIONS/SOFTWARE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET IN 2021 & 2028
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET
FIGURE 15 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, 2020
FIGURE 16 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, 2020-2028 (USD MILLION)
FIGURE 17 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, CAGR (2021-2028)
FIGURE 18 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, LIFELINE CURVE
FIGURE 19 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, 2020
FIGURE 20 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, 2020-2028 (USD MILLION)
FIGURE 21 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 22 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 23 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, 2020
FIGURE 24 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, 2020-2028 (USD MILLION)
FIGURE 25 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, CAGR (2021-2028)
FIGURE 26 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, LIFELINE CURVE
FIGURE 27 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, 2020
FIGURE 28 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, 2020-2028 (USD MILLION)
FIGURE 29 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, CAGR (2021-2028)
FIGURE 30 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, LIFELINE CURVE
FIGURE 31 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: SNAPSHOT (2020)
FIGURE 32 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY COUNTRY (2020)
FIGURE 33 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY COUNTRY (2021 & 2028)
FIGURE 34 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY COUNTRY (2020 & 2028)
FIGURE 35 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE (2021-2028)
FIGURE 36 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: COMPANY SHARE 2020 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
